(Date:12/17/2009)... Therapure Biopharma to perform fill/finish of nimotuzumab - ... Allan, Chairman and CEO of YM BioSciences Inc. ... Biopharma Inc. today announced the signing of an ... and finish services for nimotuzumab, the humanized monoclonal ... BioSciences Inc., by the Centre of Molecular Immunology ...
(Date:12/17/2009)... allows users to easily find and schedule an appointment for ... health screening, share comments, view personal stories, and connect with ... health screening company’s new site will improve its usability, ... ... OH (PRWEB) December 17, 2009 -- Visitors to Life Line ...
(Date:12/16/2009)... historians, journalists and politicians, and has been recounted everywhere ... Congress: British forces used chemical weapons on Iraqis just ... has never been fully squared with the historical record, ... According to Douglas,s research, forthcoming in the December issue ... such incident ever occurred. , Allegations of chemical ...
(Date:12/16/2009)... death from roadside bombs to freeway crashes. Traumatic injury, ... to 44, often overwhelms the body,s natural blood-clotting process. ... a team led by Erin Lavik, a new Case ... doctoral student, James P. Bertram, built synthetic platelets that ... work is published in Science Translational Medicine ., ...
Breaking Biology Technology:YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 2YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 3YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 4Website Redesign Enhances Global Health Screening Service's Online Presence 2Website Redesign Enhances Global Health Screening Service's Online Presence 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4Researchers take the inside route to halt bleeding 2... (Nasdaq: NTII ) (NTI(R)) today announced ... results of the Viprinex(TM) clinical,trial, the company has ... of acute ischemic stroke. Viprinex was recently studied ... effective in improving patient,outcome when given within six ...
... Antibody Therapeutics BETHESDA, Md., Jan. 13 ... a biopharmaceutical company developing novel, proprietary antibodies for ... today announced the publication of an article in ... revealing a novel signalling function of the epithelial ...
... Inc. a leading provider of Electronic Document Publishing Solutions and Regulatory ... the appointment of Mr. Daniel F. Orfe to Vice President, Global ... oversee Datafarm,s Regulatory Services Group. , ... Marlborough, MA ...
Other Biology Technology:Neurobiological Technologies Announces Suspension of Viprinex Development 2Neurobiological Technologies Announces Suspension of Viprinex Development 3Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling 2Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling 3Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling 4Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services 2Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services 3Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services 4BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
POU domain, class 2, transcription factor 2,...
... The CellSensor CRE-bla HEK 293T cell line ... of the cAMP response element (CRE). To ... was transduced into HEK 293T cells by ... isolate clones responsive to forskolin stimulation (Figure ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
Biology Products:Biology NavigationMedical Navigation